Mobix Labs insider plans sale of 87,025 shares

Mobix Labs, Inc. insider activity is disclosed in a Form 144 notice covering planned sales of common stock.

Rhea-AI Filing Summary

Mobix Labs, Inc. insider activity is disclosed in a Form 144 notice covering planned sales of common stock. The filing shows an intention to sell 87,025 shares of common stock through J.P. Morgan Securities LLC on NASDAQ, with an aggregate market value of 16,360.04 and 58,624,989 shares outstanding.

The seller, Philip Sansone, previously acquired 200,000 common shares on 01/31/2026 via RSU vesting from Mobix Labs, Inc. as equity compensation, with payment dated 02/03/2026. Over the prior three months, he sold 100,044 common shares for gross proceeds of 41,219.83 on 11/21/2025.

FAQ

What does Mobix Labs (MOBX) Form 144 filing disclose?

The Form 144 discloses a planned sale of Mobix Labs common stock by Philip Sansone. It covers 87,025 shares to be sold on NASDAQ through J.P. Morgan Securities LLC, providing share amounts, market value, acquisition details, and prior three-month sale history.

How many Mobix Labs (MOBX) shares are planned for sale and on which exchange?

The notice covers an intended sale of 87,025 Mobix Labs common shares. These shares are to be sold on the NASDAQ stock market, with J.P. Morgan Securities LLC listed as the broker handling the transaction for the selling security holder.

What is the aggregate market value of Mobix Labs (MOBX) shares in this Form 144?

The Form 144 lists an aggregate market value of 16,360.04 for the 87,025 Mobix Labs common shares to be sold. This value reflects the total market worth of the planned sale at the time the notice information was prepared.

When were the Mobix Labs (MOBX) shares acquired and how?

The filing shows 200,000 Mobix Labs common shares were acquired on 01/31/2026 through RSU vesting from Mobix Labs, Inc. The nature of the payment is described as equity compensation, with a payment date recorded as 02/03/2026 in the document.

What prior Mobix Labs (MOBX) stock sales by the holder are disclosed?

The notice reports that Philip Sansone sold 100,044 Mobix Labs common shares on 11/21/2025. Those earlier sales generated gross proceeds of 41,219.83, and are included to summarize securities of the issuer sold during the past three months.

How many Mobix Labs (MOBX) shares are outstanding in this Form 144?

The Form 144 states that 58,624,989 Mobix Labs common shares are outstanding. This figure provides context for the planned sale of 87,025 shares, indicating the broader share base relative to the size of the insider’s intended transaction.

Who is the selling security holder in the Mobix Labs (MOBX) Form 144?

The selling security holder identified is Philip Sansone of 1 Venture, Irvine, CA 92618. He is listed in the section summarizing securities sold during the past three months and is associated with both prior and planned sales of Mobix Labs common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/02/2026 - 04:54 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002067346
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mobix Labs, Inc.
SEC File Number	001-40621
Address of Issuer	1 Venture Suite 220 Irvine CALIFORNIA 92618
Phone	949-808-8888
Name of Person for Whose Account the Securities are To Be Sold	Philip Sansone
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	87025	16360.04	58624989	02/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/31/2026	RSU Vesting	Mobix Labs, Inc. (Issuer)			200000	02/03/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Philip Sansone 1 Venture Irvine CA 92618	Common Stock	11/21/2025	100044	41219.83

144: Remarks and Signature

Remarks
Date of Notice	02/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Philip Sansone, Mobix Labs, Inc.
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)